Biomira delays late-stage cancer vaccine trial
A manufacturing problem has forced Biomira to delay a Phase III trial of its cancer vaccine BLP25 until 2006. Biomira had planned to get started in late 2005. The manufacturing problem related to the stability of the product, or how well it would stand up to storage.
- read this AP report for more
Comments